Document is current
Any future updates will be listed below
-
Authors
Van Baak, Timothy E.
Coarfa, Cristian
Dugué, Pierre-Antoine
Fiorito, Giovanni
Laritsky, Eleonora
Baker, Maria S.
Kessler, Noah J.
Dong, Jianrong
Duryea, Jack D.
Silver, Matt J.
Saffari, Ayden
Prentice, Andrew M.
Moore, Sophie E.
Ghantous, Akram
Routledge, Michael N.
Gong, Yun Yun
Herceg, Zdenko
Vineis, Paolo
Severi, Gianluca
Hopper, John L.
Southey, Melissa C.
Giles, Graham G.
Milne, Roger L.
Waterland, Robert A.
-
Funding
Funding for this research was provided by:
Cancer Prevention and Research Institute of Texas (RP 140113, RP170295)
Medical Research Council (MC-A760-5QX00, MR/M01424X/1)
Bill and Melinda Gates Foundation (OPP1 066947)
National Health and Medical Research Council (APP1011618, APP1026892)
Agricultural Research Service (CRIS 3092-5-001-059)
- License Information
-
More Information
Article History
Received: 13 October 2017
Accepted: 6 December 2017
First Online: 9 January 2018
Ethics approval and consent to participate
: The Melbourne Collaborative Cohort Study was approved by the Human Research Ethics Committee of Cancer Council Victoria. For the ENID Trial, ethical approvals were obtained from the joint Gambia Government/MRC Unit, The Gambia Ethics Committee. In both the Melbourne and Gambia studies, all participants provided informed consent in accordance with the Helsinki Declaration.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
